🇺🇸 FDA
Patent

US 10682425

Engineered B lymphocytes and compositions having micro-RNA and methods for making and using them

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 10682425 (Engineered B lymphocytes and compositions having micro-RNA and methods for making and using them) held by The Regents of the University of California expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K2239/49, A61K31/7105